The availability, pricing and affordability of three essential asthma medicines in 52 low- and middle-income countries.
Babar, Zaheer-Ud-Din
The availability, pricing and affordability of three essential asthma medicines in 52 low- and middle-income countries. [electronic resource] - PharmacoEconomics Nov 2013 - 1063-82 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1179-2027
10.1007/s40273-013-0095-9 doi
Albuterol--economics
Anti-Asthmatic Agents--economics
Asthma--drug therapy
Beclomethasone--economics
Budesonide--economics
Cross-Sectional Studies
Data Collection
Developing Countries
Drug Costs
Glucocorticoids--economics
Health Services Accessibility--statistics & numerical data
Humans
Reimbursement Mechanisms
The availability, pricing and affordability of three essential asthma medicines in 52 low- and middle-income countries. [electronic resource] - PharmacoEconomics Nov 2013 - 1063-82 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1179-2027
10.1007/s40273-013-0095-9 doi
Albuterol--economics
Anti-Asthmatic Agents--economics
Asthma--drug therapy
Beclomethasone--economics
Budesonide--economics
Cross-Sectional Studies
Data Collection
Developing Countries
Drug Costs
Glucocorticoids--economics
Health Services Accessibility--statistics & numerical data
Humans
Reimbursement Mechanisms